Outcomes of Delivery in Patients With Dyspareunia


The focus of this pilot study is to determine if a woman who experiences pain during sexual intercourse has a higher risk of complications during labor and delivery secondary to pelvic floor dysfunction, anxiety and intolerance towards pelvic examinations. Furthermore, it is unclear whether women with prepartum dyspareunia experience an improvement following vaginal delivery. While physicians may expect that vaginal birth improves dyspareunia due to the stretching effect on pelvic floor, to date, there is insufficient evidence to support this claim. The Investigators plan to prospectively study 200 patients at our Institution, collect information regarding birth and follow them, via questionnaires, regarding their dyspareunia postpartum.

Full Title of Study: “Outcomes of Delivery in Patients With Dyspareunia- A Prospective Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: September 2016

Arms, Groups and Cohorts

  • Definite diagnosis of dyspareunia
    • Patients who report dyspareunia, and whose dyspareunia was evaluated prior to delivery by a caregiver experienced with sexual pain disorders, with definite diagnosis.
  • No definite diagnosis of dyspareunia
    • Patients who report dyspareunia but were not evaluated prior to delivery or were evaluated inappropriately (i.e. “yeast infection” without cultures, “inflammation” and other vague definitions).
  • Patients without dyspareunia
    • Patients without dyspareunia- those who report non painful sexual intercourse. This group of patients will be used as a control group.

Clinical Trial Outcome Measures

Primary Measures

  • Obstetrical outcome of women with a history of dyspareunia
    • Time Frame: 3 months -1 year
    • The Investigators will record the mode of delivery (vaginal, instrumental or cesarean section), length of the second stage of labor, use of anesthetics, perineal tears and\or episiotomies, and newborn’s birth weight. The evaluation will be done prospectively, comparing data with matched controls without a history of dyspareunia.

Secondary Measures

  • Rate of alleviation of dyspareunia following vaginal delivery as assessed through patient questionnaires.
    • Time Frame: 2 years

Participating in This Clinical Trial

Inclusion Criteria

1. 200 nulliparous women admitted to the Labor and Delivery Department at the Hadassah Medical Center, above the age of 18. 2. Able and willing to read, understand, and sign the Informed Consent Form and questionnaire. 3. Agree to be contacted in the future to complete telephone questionnaires. Exclusion Criteria:

1. Induction of labor 2. Placental abruption, placenta previa 3. Malpresentation 4. Non reassuring fetal heart rate upon admission 5. Any other contraindication for vaginal delivery 6. Multifetal pregnancy

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: 50 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Hadassah Medical Organization
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Ahinoam Lev-Sagie, MD, Principal Investigator, Hadassah Medical Organization

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.